Literature DB >> 1997651

The immunodeficient scid mouse as a model for human lymphatic filariasis.

F K Nelson1, D L Greiner, L D Shultz, T V Rajan.   

Abstract

The C.B.-17-scid/scid mouse (hereafter referred to as the scid mouse) is homozygous for a recessive mutation at a locus that influences the assembly of intact immunoglobulin and T cell receptor genes. Therefore, scid mice cannot generate functional B or T lymphocytes, are profoundly immunodeficient, and have been reported to be receptive to reconstitution with human immune cells. In the present study, we injected scid mice with infective larvae of the human filarial parasite Brugia malayi. Within 6-10 wk after subcutaneous injection of infective L3 larvae, both male and female worms were observed in various stages of development in 90% of the mice. In animals tested 8 weeks or more after infection, microfilariae were detected in the blood or peritoneal cavity of 52% of the mice examined. Adult worms were observed in the lymphatics of the infected scid mice, where their presence was associated with lymphangitis and lymphangiectasia. These results suggest that the scid mouse model of lymphatic filariasis may be important in investigation of the interaction of the murine, and possibly the human, immune system with the lymphatic filarial parasite.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1997651      PMCID: PMC2118823          DOI: 10.1084/jem.173.3.659

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  11 in total

1.  T cell-independent macrophage activation in scid mice.

Authors:  G J Bancroft; R D Schreiber; E R Unanue
Journal:  Curr Top Microbiol Immunol       Date:  1989       Impact factor: 4.291

2.  Development of subperiodic Brugia malayi in the jird, Meriones unguiculatus, with notes on infections in other rodents.

Authors:  L R Ash; J M Riley
Journal:  J Parasitol       Date:  1970-10       Impact factor: 1.276

3.  Diethylcarbamazine-mediated clearance of Brugia pahangi microfilariae in immunodeficient nude mice.

Authors:  A C Vickery; J K Nayar; M L Tamplin
Journal:  Am J Trop Med Hyg       Date:  1985-05       Impact factor: 2.345

4.  A severe combined immunodeficiency mutation in the mouse.

Authors:  G C Bosma; R P Custer; M J Bosma
Journal:  Nature       Date:  1983-02-10       Impact factor: 49.962

5.  Effect of immune reconstitution on resistance to Brugia pahangi in congenitally athymic nude mice.

Authors:  A C Vickery; A L Vincent; W A Sodeman
Journal:  J Parasitol       Date:  1983-06       Impact factor: 1.276

6.  Lymphatic filariasis. Brugia malayi infection in the ferret (Mustela putorius furo).

Authors:  S A Hines; R B Crandall; C A Crandall; J P Thompson
Journal:  Am J Pathol       Date:  1989-06       Impact factor: 4.307

7.  Immunity to Brugia pahangi in athymic nude and normal mice: eosinophilia, antibody and hypersensitivity responses.

Authors:  A C Vickery; A L Vincent
Journal:  Parasite Immunol       Date:  1984-11       Impact factor: 2.280

8.  The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function.

Authors:  J M McCune; R Namikawa; H Kaneshima; L D Shultz; M Lieberman; I L Weissman
Journal:  Science       Date:  1988-09-23       Impact factor: 47.728

9.  Long-term human hematopoiesis in the SCID-hu mouse.

Authors:  R Namikawa; K N Weilbaecher; H Kaneshima; E J Yee; J M McCune
Journal:  J Exp Med       Date:  1990-10-01       Impact factor: 14.307

10.  Evidence of functional lymphocytes in some (leaky) scid mice.

Authors:  G C Bosma; M Fried; R P Custer; A Carroll; D M Gibson; M J Bosma
Journal:  J Exp Med       Date:  1988-03-01       Impact factor: 14.307

View more
  40 in total

Review 1.  SCID mice in the study of human autoimmune diseases.

Authors:  M A Duchosal
Journal:  Springer Semin Immunopathol       Date:  1992

2.  Granuloma formation around filarial larvae triggered by host responses to an excretory/secretory antigen.

Authors:  Yashodhara Dash; Manish Ramesh; Ramaswamy Kalyanasundaram; Gnanasekar Munirathinam; Leonard D Shultz; T V Rajan
Journal:  Infect Immun       Date:  2010-11-15       Impact factor: 3.441

Review 3.  A comprehensive, model-based review of vaccine and repeat infection trials for filariasis.

Authors:  C Paul Morris; Holly Evans; Sasha E Larsen; Edward Mitre
Journal:  Clin Microbiol Rev       Date:  2013-07       Impact factor: 26.132

Review 4.  Lymphatics in human lymphatic filariasis: in vitro models of parasite-induced lymphatic remodeling.

Authors:  Sasisekhar Bennuru; Thomas B Nutman
Journal:  Lymphat Res Biol       Date:  2009-12       Impact factor: 2.589

Review 5.  SCID mice and the study of parasitic disease.

Authors:  K B Seydel; S L Stanley
Journal:  Clin Microbiol Rev       Date:  1996-04       Impact factor: 26.132

6.  Interleukin-10- and transforming growth factor β-independent regulation of CD8⁺ T cells expressing type 1 and type 2 cytokines in human lymphatic filariasis.

Authors:  Rajamanickam Anuradha; Parakkal Jovvian George; Paul Kumaran; Thomas B Nutman; Subash Babu
Journal:  Clin Vaccine Immunol       Date:  2014-09-24

7.  Interleukin 1 (IL-1)- and IL-23-mediated expansion of filarial antigen-specific Th17 and Th22 cells in filarial lymphedema.

Authors:  R Anuradha; P Jovvian George; V Chandrasekaran; P Paul Kumaran; Thomas B Nutman; Subash Babu
Journal:  Clin Vaccine Immunol       Date:  2014-05-07

Review 8.  Insights into the pathogenesis of disease in human lymphatic filariasis.

Authors:  Thomas B Nutman
Journal:  Lymphat Res Biol       Date:  2013-09       Impact factor: 2.589

9.  Effect of Diethylcarbamazine (DEC) on prostaglandin levels in Wuchereria bancrofti infected microfilaraemics.

Authors:  T Sankari; S L Hoti; L K Das; V Govindaraj; P K Das
Journal:  Parasitol Res       Date:  2013-03-24       Impact factor: 2.289

10.  Lymphangiogenesis and lymphatic remodeling induced by filarial parasites: implications for pathogenesis.

Authors:  Sasisekhar Bennuru; Thomas B Nutman
Journal:  PLoS Pathog       Date:  2009-12-11       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.